206.30 USD
+2.71
1.33%
At close Feb 14, 4:00 PM EST
After hours
206.30
+0.00
0.00%
1 day
1.33%
5 days
0.22%
1 month
-13.18%
3 months
-13.82%
6 months
-23.05%
Year to date
-10.23%
1 year
-16.81%
5 years
24.31%
10 years
213.48%
 

About: In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.

Employees: 63,000

0
Funds holding %
of 6,831 funds
0
Analysts bullish %
of 8 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

139% more first-time investments, than exits

New positions opened: 196 | Existing positions closed: 82

55% more call options, than puts

Call options by funds: $2.23B | Put options by funds: $1.43B

31% more funds holding in top 10

Funds holding in top 10: 74 [Q2] → 97 (+23) [Q3]

4% more funds holding

Funds holding: 2,140 [Q2] → 2,229 (+89) [Q3]

5% more capital invested

Capital invested by funds: $153B [Q2] → $160B (+$6.98B) [Q3]

0% less repeat investments, than reductions

Existing positions increased: 847 | Existing positions reduced: 850

3.06% less ownership

Funds ownership: 81.59% [Q2] → 78.53% (-3.06%) [Q3]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$240
16%
upside
Avg. target
$262
27%
upside
High target
$290
41%
upside

8 analyst ratings

positive
63%
neutral
38%
negative
0%
Citigroup
Patrick Donnelly
27% 1-year accuracy
8 / 30 met price target
28%upside
$265
Buy
Maintained
30 Jan 2025
RBC Capital
Conor McNamara
3% 1-year accuracy
1 / 36 met price target
34%upside
$277
Outperform
Reiterated
30 Jan 2025
Baird
Catherine Schulte
10% 1-year accuracy
2 / 20 met price target
25%upside
$258
Outperform
Maintained
30 Jan 2025
Wells Fargo
Brandon Couillard
14% 1-year accuracy
3 / 22 met price target
16%upside
$240
Equal-Weight
Maintained
30 Jan 2025
Barclays
Luke Sergott
27% 1-year accuracy
13 / 49 met price target
16%upside
$240
Equal-Weight
Maintained
30 Jan 2025

Financial journalist opinion

Based on 15 articles about DHR published over the past 30 days

Positive
Seeking Alpha
2 days ago
All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On
Thank you to the Seeking Alpha community for your support! Reaching 40,000 followers is a dream come true. Your feedback fuels my work. I've invested 91% of my net worth in 23 high-conviction dividend stocks. Focused on wide-moat businesses, I prioritize quality and long-term growth over yield. My portfolio has outperformed the S&P 500, and I'm confident in its future. I expect a rotation to value stocks, and I'll keep sharing insights to grow together.
All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On
Positive
Morningstar
5 days ago
3 Top Value Stocks to Buy and Hold for 2025
These high-quality companies are solid—and their stocks look cheap.
3 Top Value Stocks to Buy and Hold for 2025
Positive
Seeking Alpha
6 days ago
Where I'd Put $10,000 Right Now - My Best Dividend Picks For Income And Growth
I started investing with a modest $4,000, now growing it into a 23-stock portfolio. The median net worth varies by age, but most can invest $10,000 for growth. The goal here isn't to push random picks, but to offer long-term dividend ideas. I connect my choices to the broader economic picture, from undervalued essentials to GARP stocks. In this article, I highlight undervalued consumer staples, GARP stocks, and investment ideas linked to potential political changes, all aimed at steady dividend growth.
Where I'd Put $10,000 Right Now - My Best Dividend Picks For Income And Growth
Negative
Benzinga
2 weeks ago
Danaher Analysts Cut Their Forecasts After Downbeat Earnings
Danaher Corporation DHR reported weaker-than-expected fourth-quarter earnings on Wednesday.
Danaher Analysts Cut Their Forecasts After Downbeat Earnings
Neutral
Zacks Investment Research
2 weeks ago
Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y
DHR's fourth-quarter sales increase 2.1% year over year, benefiting from the solid performance of its Life Sciences and Biotechnology segments.
Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y
Positive
Zacks Investment Research
2 weeks ago
Danaher (DHR) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Danaher (DHR) Reports Q4 Earnings: What Key Metrics Have to Say
Neutral
Seeking Alpha
2 weeks ago
Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript
Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript
Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript
Negative
Zacks Investment Research
2 weeks ago
Danaher (DHR) Lags Q4 Earnings Estimates
Danaher (DHR) came out with quarterly earnings of $2.14 per share, missing the Zacks Consensus Estimate of $2.17 per share. This compares to earnings of $2.09 per share a year ago.
Danaher (DHR) Lags Q4 Earnings Estimates
Negative
Reuters
2 weeks ago
Danaher misses quarterly profit estimates on weak biotech demand
Danaher on Wednesday missed Wall Street estimates for fourth-quarter profit due to soft demand for tools and services used in drug development by its biotech and pharmaceutical clients.
Danaher misses quarterly profit estimates on weak biotech demand
Neutral
PRNewsWire
2 weeks ago
Danaher Reports Fourth Quarter and Full Year 2024 Results
WASHINGTON , Jan. 29, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2024.  All results in this release reflect only continuing operations unless otherwise noted.
Danaher Reports Fourth Quarter and Full Year 2024 Results
Charts implemented using Lightweight Charts™